首页> 美国卫生研究院文献>Molecular Cancer >LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells
【2h】

LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells

机译:LMP1-增强的κ内含子增强子活性通过鼻咽癌细胞中的NF-κB和AP-1途径促进Igκ轻链的表达上调

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundExpression of kappa gene is under the control of distinct cis-regulatory elements, including the kappa intron enhancer (iEκ) and the kappa 3' enhancer (3'Eκ). The active enhancers and expression of immunoglobulin is generally considered to be restricted to B lymphocytes. However, accumulating evidence indicated that epithelial cancer cells, including nasopharyngeal carcinoma (NPC) cell lines, express immunoglobulins. The mechanisms underlying the expression of Igs in nonlymphoid cells remain unknown. On the basis of our previous finding that expression of kappa light chain in NPC cells can be upregulated by EBV-encoded latent membrane protein 1(LMP1) through the activation of NF-κB and AP-1 signaling pathways, we thus use NPC cells as model to further explore the molecular mechanisms of nonlymphoid cells expressing Ig kappa.
机译:背景Kappa基因的表达受独特的顺式调控元件控制,包括Kappa内含子增强子(iEκ)和Kappa 3'增强子(3'Eκ)。通常认为活性增强剂和免疫球蛋白的表达仅限于B淋巴细胞。但是,越来越多的证据表明,包括鼻咽癌(NPC)细胞系在内的上皮癌细胞表达免疫球蛋白。 Igs在非淋巴细胞中表达的潜在机制仍然未知。根据我们先前的发现,EBV编码的潜伏膜蛋白1(LMP1)可通过激活NF-κB和AP-1信号通路来上调NPC细胞中Kappa轻链的表达,因此我们将NPC细胞用作进一步探索表达Igκ的非淋巴细胞的分子机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号